Barinthus Biotherapeutics plc. — All Filings
239 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
3/A
4
4/A
424B4
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | OWNERSHIP DOCUMENT | 0001104659-21-061217 | May 4, 2021 | Apr 29, 2021 |
| 4 | FORM 4 | 0001567619-21-008855 | May 3, 2021 | Apr 30, 2021 |
| 3 | FORM 3 | 0001567619-21-008853 | May 3, 2021 | Apr 29, 2021 |
| S-8 | FORM S-8 | 0001104659-21-059029 | Apr 30, 2021 | — |
| 424B4 | 424B4 | 0001104659-21-058759 | Apr 30, 2021 | — |
| CERT | — | 0001354457-21-000528 | Apr 30, 2021 | — |
| SEC STAFF LETTER | — | 9999999997-21-002243 | Apr 29, 2021 | — |
| EFFECT | — | 9999999995-21-001631 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057937 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057861 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057860 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057858 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057857 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057856 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057854 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057853 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057852 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057851 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057850 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057848 | Apr 29, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-057847 | Apr 29, 2021 | — |
| 8-A12B | FORM 8-A12G | 0001104659-21-055601 | Apr 27, 2021 | — |
| CORRESP | — | 0001104659-21-055599 | Apr 27, 2021 | — |
| CORRESP | — | 0001104659-21-055592 | Apr 27, 2021 | — |
| CORRESP | — | 0001104659-21-055583 | Apr 27, 2021 | — |
| S-1/A | S-1/A | 0001104659-21-055576 | Apr 27, 2021 | — |
| UPLOAD | — | 0000000000-21-005276 | Apr 26, 2021 | — |
| S-1/A | S-1/A | 0001104659-21-054698 | Apr 26, 2021 | — |
| CORRESP | — | 0001104659-21-051436 | Apr 16, 2021 | — |
| CORRESP | — | 0001104659-21-048703 | Apr 9, 2021 | — |
| S-1 | S-1 | 0001104659-21-048698 | Apr 9, 2021 | — |
| UPLOAD | — | 0000000000-21-003928 | Apr 1, 2021 | — |
| DRS/A | — | 0001104659-21-039865 | Mar 23, 2021 | — |
| SEC STAFF LETTER | — | 9999999997-21-001239 | Mar 17, 2021 | — |
| DRS/A | — | 0001104659-21-034523 | Mar 10, 2021 | — |
| DRSLTR | — | 0001104659-21-009344 | Jan 29, 2021 | — |
| DRS/A | — | 0001104659-21-009339 | Jan 29, 2021 | — |
| UPLOAD | — | 0000000000-21-000669 | Jan 19, 2021 | — |
| DRS | — | 0001104659-20-139201 | Dec 23, 2020 | — |